During the past decade, Ankara University Medical Faculty conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 30 clinical trials were completed, i.e. on average, 46.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 16 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ankara University Medical Faculty" #1 sponsor was "Ankara University" with 18 trials, followed by "Hoffmann-La Roche" with 14 trials sponsored, "Janssen Research & Development, LLC" with 9 trials sponsored, "Takeda" with 8 trials sponsored and "Celgene" with 8 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara University Medical Faculty" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Turkish Neurological Society" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "Abbott Nutrition" with 1 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Ankara University Medical Faculty" are "Multiple Myeloma" (8 trials), "Colitis, Ulcerative" (4 trials), "Crohn Disease" (4 trials), "Crohn's Disease" (4 trials) and "Anemia" (3 trials). Many other conditions were trialed in "Ankara University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Ankara University Medical Faculty" are "Drug" (60 trials), "Other" (12 trials), "Biological" (8 trials), "Procedure" (7 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Dexamethasone" (6 trials), "Bortezomib" (4 trials), "Daratumumab" (4 trials) and "Faricimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Ankara University Medical Faculty" are 84 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ankara University Medical Faculty". undefined are not yet recruiting, 17 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Ankara University Medical Faculty, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Ankara University Medical Faculty, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 12 trials that are defined as “Not Applicable".